← Leaderboards
Donald E Mager
State University Of New York At Buffalo
$1,901,673
Attributed
$4,213,675
Total exposure
4
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $780.4K · FY2010–23$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,213,675 · 4
By mechanism
U01$2,376,010 · 1
R01$1,287,312 · 1
R21$398,683 · 1
U54$151,670 · 1
Top collaborators
- William J Jusko4 shared
- Wojciech Krzyzanski4 shared
- David A. Horne2 shared
- Jeannine S Mccune2 shared
- Jun Qu2 shared
- Robert M Straubinger2 shared
Most similar at State University Of New York At Buffalo
Same institution · by research overlap
- Ronald Berezney$2,863,723
- Kathleen M Tornatore$3,934,914
- Jonathan F Lovell$9,226,863
- Robert M Straubinger$4,875,752
- Elaine M Haase$156,000
Others in their field
Top investigators on “Link”
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- David R. Weir · University Of Michigan At Ann Arbor$206,261,870
- Clare E Reimers · Gordon Research Conferences$205,233,456
- Demian A Bailey · Oregon State University$205,233,456
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Greg Ulses · Consortium For Ocean Leadership, Inc$140,113,248
Research focus
LinkPharmacodynamicsMathematical ModelPharmaceutical PreparationsDosePharmacodynamic ModelRegimenBaseDrug KineticsPhysiologicalComplexCharacteristicsPharmacologyPre-ClinicalInsightResponseData SetCellsSignal TransductionClinical DataScheduleDisease ProgressionPlasmaDrug Effect Disorder
Grant awards (15)
Optimizing GVHD Prevention with Systems Pharmacology Models$588,002
U01 · FY2023 · CA
Optimizing GVHD Prevention with Systems Pharmacology Models$588,002
U01 · FY2022 · CA
Optimizing GVHD Prevention with Systems Pharmacology Models$600,003
U01 · FY2021 · CA
Optimizing GVHD Prevention with Systems Pharmacology Models$600,003
U01 · FY2020 · CA
Large-scale proteome-wide analysis with high accuracy/precision to guide pancreatic cancer therapy development$180,399
R21 · FY2020 · CA
Large-scale proteome-wide analysis with high accuracy/precision to guide pancreatic cancer therapy development$218,284
R21 · FY2019 · CA
PHARMACOMETRICS (PKPD CORE) Subaward$27,415
U54 · FY2015 · HD · contact PI
PHARMACOMETRICS (PKPD CORE) Subaward$26,647
U54 · FY2014 · HD · contact PI
Mathematical Models in Pharmacodynamics$312,509
R01 · FY2013 · GM
PHARMACOMETRICS (PKPD CORE) Subaward$27,414
U54 · FY2013 · HD · contact PI
Mathematical Models in Pharmacodynamics$323,844
R01 · FY2012 · GM
PHARMACOMETRICS (PKPD CORE) Subaward$27,415
U54 · FY2012 · HD · contact PI
Mathematical Models in Pharmacodynamics$323,844
R01 · FY2011 · GM
PHARMACOMETRICS (PKPD CORE) Subaward$42,779
U54 · FY2011 · HD · contact PI
Mathematical Models in Pharmacodynamics$327,115
R01 · FY2010 · GM